Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Pediatric Sickle Cell Pain in the Emergency Department
NCT07682662Phase 4Not yet recruiting
- Sponsor
- University of Mississippi Medical Center
- Start
- Aug 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in sickle cell disease (SCD), sponsored by University of Mississippi Medical Center. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT07682662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07682662.